NCT02665195 Prospective Registry of Multiplex Testing (PROMPT) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02663908 A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease Status TERMINATED Phase PHASE3
NCT02658279 Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype Status ACTIVE_NOT_RECRUITING Phase NA
NCT02657486 BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder Status COMPLETED Phase NA
NCT02650752 Intermittent High-Dose Lapatinib in Tandem With Capecitabine for HER2 Overexpressed/Amplified Metastatic Breast Cancer With Central Nervous System (CNS) Metastases Status COMPLETED Phase PHASE1
NCT02650648 Humanized Anti-GD2 Antibody Hu3F8 and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma Status COMPLETED Phase PHASE1
NCT02649972 Single-agent Cobimetinib for Adults With Histiocytic Disorders Status COMPLETED Phase PHASE2
NCT02647190 Intravenous Erwinia Chrysanthemi Asparaginase in Patients With Newly Diagnosed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Aged 60 Years or Older Status WITHDRAWN Phase PHASE1
NCT02643498 A Dose Escalation Trial of Stereotactic Body Radiotherapy (SBRT) After Induction Chemotherapy for Locally Advanced Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT02642913 Study of Enzalutamide With and Without Sorafenib in Advanced Hepatocellular Carcinoma Patients Status COMPLETED Phase PHASE1
NCT02639767 Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural Mesothelioma Status WITHDRAWN Phase PHASE1
NCT02633137 Sequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell Lymphoma Status COMPLETED Phase PHASE2
NCT02633111 DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02628912 Cardiopulmonary Fitness in Long-Term Survivors of HPV-related Oropharynx Cancers Status WITHDRAWN Phase N/A
NCT02615054 Assessment for Long-Term Cardiovascular Impairment Associated With Trastuzumab Cardiotoxicity in HER2-Positive Breast Cancer Survivors Status COMPLETED Phase N/A
NCT02609737 Theranostics of Radiolabeled Somatostatin Antagonists 68Ga-DOTA-JR11 and 177Lu-DOTA-JR11 in Patients With Neuroendocrine Tumors Status COMPLETED Phase NA
NCT02608619 Uptake and Biodistribution of 18F-fluorocholine in Histiocytic Disorders by PET Imaging and Biopsy Measurement Status COMPLETED Phase N/A
NCT02605486 Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2